Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies [Yahoo! Finance]
Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television [Yahoo! Finance]
Lantern Pharma (NASDAQ:LTRN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.